TSBX logo

Turnstone Biologics Stock Price

Symbol: NasdaqCM:TSBXMarket Cap: US$8.1mCategory: Pharmaceuticals & Biotech

TSBX Share Price Performance

US$0.35
-2.00 (-85.06%)
US$0.35
-2.00 (-85.06%)
Price US$0.35

TSBX Community Narratives

There are no narratives available yet.

TSBX Community Fair Values

    Recent TSBX News & Updates

    No updates

    Turnstone Biologics Corp. Key Details

    US$0

    Revenue

    US$56.3m

    Cost of Revenue

    -US$56.3m

    Gross Profit

    US$6.7m

    Other Expenses

    -US$63.0m

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -2.72
    Gross Margin
    0%
    Net Profit Margin
    0%
    Debt/Equity Ratio
    0%

    Turnstone Biologics Corp. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About TSBX

    Founded
    2014
    Employees
    8
    CEO
    Sammy Farah
    WebsiteView website
    turnstonebio.com

    Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California.

    U.S. Market Performance

    • 7 Days: -1.2%
    • 3 Months: 13.1%
    • 1 Year: 22.8%
    • Year to Date: 7.3%
    Over the last 7 days, the market has dropped 1.2%, driven by a loss of 4.7% in the Consumer Discretionary sector. In contrast to the last week, the market is actually up 23% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading